Should FMC’s (FMC) Dual-Mode Rimisoxafen Filing Reshape Its Crop Protection Innovation Narrative?

Simply Wall St.07-16

In July 2026, FMC Corporation announced it had submitted the first global regulatory dossier for its new herbicide active ingredient, rimisoxafen, to the U.S. Environmental Protection Agency for use ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2651189334?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/2023000-choice2-main-header/1585186853880","is_english":true,"pubTime":"2026-07-16 08:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2651189334","market":"hk","top_or_hot":-1,"title":"Should FMC’s (FMC) Dual-Mode Rimisoxafen Filing Reshape Its Crop Protection Innovation Narrative?","media":"Simply Wall St.","content":"<div>\n<p>In July 2026, FMC Corporation announced it had submitted the first global regulatory dossier for its new herbicide active ingredient, rimisoxafen, to the U.S. Environmental Protection Agency for use ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-fmc/fmc/news/should-fmcs-fmc-dual-mode-rimisoxafen-filing-reshape-its-cro\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Should FMC’s (FMC) Dual-Mode Rimisoxafen Filing Reshape Its Crop Protection Innovation Narrative?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShould FMC’s (FMC) Dual-Mode Rimisoxafen Filing Reshape Its Crop Protection Innovation Narrative?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-07-16 08:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/materials/nyse-fmc/fmc/news/should-fmcs-fmc-dual-mode-rimisoxafen-filing-reshape-its-cro><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In July 2026, FMC Corporation announced it had submitted the first global regulatory dossier for its new herbicide active ingredient, rimisoxafen, to the U.S. Environmental Protection Agency for use ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/materials/nyse-fmc/fmc/news/should-fmcs-fmc-dual-mode-rimisoxafen-filing-reshape-its-cro\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"QTOC","symbol_name":"Innovator Growth Accelerated Plus ETF - October","start_time":0,"source_url":"https://simplywall.st/stocks/us/materials/nyse-fmc/fmc/news/should-fmcs-fmc-dual-mode-rimisoxafen-filing-reshape-its-cro","article_id":"2651189334","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/2023000-choice2-main-header/1585186853880"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-fmc/fmc/news/should-fmcs-fmc-dual-mode-rimisoxafen-filing-reshape-its-cro","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2651189334","pubTimestamp":1784162640,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"In July 2026, FMC Corporation announced it had submitted the first global regulatory dossier for its new herbicide active ingredient, rimisoxafen, to the U.S. Environmental Protection Agency for use on corn, soybean, sunflower and select pulse crops.\nAs the first herbicide ever classified by the Global Herbicide Resistance Action Committee as having a dual mode of action, rimisoxafen underscores the depth of FMC's recent innovation push alongside Isoflex and Dodhylex actives.\nWe will now...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"QTOC":"Innovator Growth Accelerated Plus ETF - October","AGIX":"通用人工智能 ETF-AGIX","CHAT":"ROUNDHILL GENERATIVE AI & TECHNOLOGY ETF","BK4093":"化肥与农用药剂","FMC":"FMC Corp.","ARTY":"ISHARES FUTURE AI & TECH ETF","BK4588":"碎股","AIPO":"Defiance AI and Power Infrastructure ETF","BK4585":"ETF&股票定投概念","LU0471298777.SGD":"Blackrock Nutrition A2 SGD-H","LU0385154629.USD":"贝莱德营养科学基金A2","BK4545":"锂电池","VTHR":"Vanguard Russell 3000 ETF"},"translate_title":"FMC (FMC) 的双模式利米沙芬申请是否应该重塑其作物保护创新叙事？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AIPO":0.83,"FMC":1.5,"VTHR":0.73,"AGIX":0.73,"ARTY":0.73,"CHAT":0.73,"QTOC":0.73},"content_text":"In July 2026, FMC Corporation announced it had submitted the first global regulatory dossier for its new herbicide active ingredient, rimisoxafen, to the U.S. Environmental Protection Agency for use on corn, soybean, sunflower and select pulse crops. As the first herbicide ever classified by the Global Herbicide Resistance Action Committee as having a dual mode of action, rimisoxafen underscores the depth of FMC's recent innovation push alongside Isoflex and Dodhylex actives. We will now examine how this dual mode of action herbicide submission could influence FMC's crop protection pipeline-driven investment narrative. We've uncovered the 10 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.AdvertisementFMC Investment Narrative RecapTo own FMC today, you need to believe its R&D engine and new actives can eventually offset regulatory, pricing, and balance sheet pressures. The rimisoxafen submission strengthens the pipeline story, but its impact on near term catalysts, such as deleveraging and margin stabilization, is not yet material given regulatory and commercial timing uncertainties. The recent US$403.2 million equity investment by Tessenderlo Group is the most relevant backdrop here. Together with the rimisoxafen filing and existing Isoflex and Dodhylex submissions, it highlights how FMC is pairing fresh capital with a more innovation centric, pipeline driven turnaround, even as near term earnings and cash coverage of interest and dividends remain under pressure. Yet, in contrast to the promising innovation story, investors should be aware that rising regulatory barriers and shifting farming practices could... Read the full narrative on FMC (it's free!)FMC's narrative projects $4.0 billion revenue and $286.1 million earnings by 2029. This requires 5.3% yearly revenue growth and an earnings increase of about $2.8 billion from -$2.5 billion today.Uncover how FMC's forecasts yield a $17.53 fair value, a 62% upside to its current price.Exploring Other PerspectivesFMC 1-Year Stock Price Chart While rimisoxafen highlights FMC’s innovation push, the most bearish analysts were still assuming only 4.4% annual revenue growth and US$282.0 million earnings by 2029, reminding you that opinions can differ widely on whether new actives can offset tightening pesticide rules and a faster shift toward organic farming.Explore 5 other fair value estimates on FMC - why the stock might be worth just $12.00!Decide For YourselfDon't just follow the ticker - dig into the data and build a conviction that's truly your own.A great starting point for your FMC research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.Our free FMC research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate FMC's overall financial health at a glance.Looking For Alternative Opportunities?Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:Rare earth metals are the new gold rush. Find out which 29 stocks are leading the charge.Capitalize on the AI infrastructure supercycle with our selection of the 52 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 16 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: AI Stock Screener & AlertsOur new AI Stock Screener scans the market every day to uncover opportunities.• Dividend Powerhouses (3%+ Yield)• Undervalued Small Caps with Insider Buying• High growth Tech and AI CompaniesOr build your own from over 50 metrics.Explore Now for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2651189334","isCrawlerRequest":true}